XKRX
140410
Market cap727mUSD
May 23, Last price
37,150.00KRW
1D
-2.37%
1Q
29.90%
Jan 2017
61.52%
IPO
98.66%
Name
Mezzion Pharma Co Ltd
Chart & Performance
P/E
—
P/S
115.36
EPS
—
Div Yield, %
—
Shrs. gr., 5y
2.74%
Rev. gr., 5y
-13.63%
Revenues
8.61b
-72.85%
Net income
-19.48b
L+53.02%
CFO
-18.49b
L+67.73%
Earnings
Aug 11, 2025
Profile
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | ||||||
Revenues | 8,611,621 -72.85% | 31,720,932 3.24% | 30,726,176 15.28% | |||
Cost of revenue | 17,179,187 | 38,145,675 | 44,136,237 | |||
Unusual Expense (Income) | ||||||
NOPBT | (8,567,566) | (6,424,743) | (13,410,061) | |||
NOPBT Margin | ||||||
Operating Taxes | 4,942,971 | 248,073 | 388,233 | |||
Tax Rate | ||||||
NOPAT | (13,510,537) | (6,672,816) | (13,798,293) | |||
Net income | (19,476,775) 53.02% | (12,728,376) -64.93% | (36,297,830) 166.84% | |||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | 1,726,332 | 48,652,841 | 312,000 | |||
BB yield | -0.19% | -4.42% | -0.09% | |||
| Debt | ||||||
Debt current | 694,375 | 499,577 | 1,062,980 | |||
Long-term debt | 2,537,307 | 4,275,771 | ||||
Deferred revenue | ||||||
Other long-term liabilities | 91,985 | 1,089,728 | 76,829 | |||
Net debt | (11,079,674) | (41,563,697) | (25,908,410) | |||
| Cash flow | ||||||
Cash from operating activities | (18,489,352) | (11,023,301) | (12,074,642) | |||
CAPEX | (590,489) | (529,292) | (1,761,023) | |||
Cash from investing activities | (9,576,382) | (25,555,486) | 17,409,825 | |||
Cash from financing activities | 670,322 | 47,214,017 | (615,787) | |||
FCF | (13,184,878) | (5,282,439) | (12,997,435) | |||
| Balance | ||||||
Cash | 28,616,921 | 58,246,153 | 32,399,067 | |||
Long term investments | (14,305,565) | (16,182,878) | (1,151,906) | |||
Excess cash | 13,880,775 | 40,477,228 | 29,710,852 | |||
Stockholders' equity | (128,166,690) | (108,919,471) | (73,016,432) | |||
Invested Capital | 175,937,027 | 171,953,139 | 102,021,243 | |||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | 29,731 | 28,223 | 26,729 | |||
Price | 30,850.00 -20.90% | 39,000.00 200.00% | 13,000.00 -82.04% | |||
Market cap | 917,192,095 -16.67% | 1,100,679,996 216.76% | 347,475,544 -82.01% | |||
EV | 906,112,421 | 1,059,116,299 | 321,567,134 | |||
EBITDA | (7,609,770) | (4,878,326) | (11,751,754) | |||
EV/EBITDA | ||||||
Interest | 300,789 | 164,809 | 423,444 | |||
Interest/NOPBT | ||||||